Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata(Harvard University), Matthew J. Niederst(Harvard University), Hannah L. Archibald(Massachusetts General Hospital), María Gomez‐Caraballo(Massachusetts General Hospital), Faria M. Siddiqui(Massachusetts General Hospital), Hillary E. Mulvey(Massachusetts General Hospital), Yosef E. Maruvka(Broad Institute), Fei Ji(Massachusetts General Hospital), Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna(Candiolo Cancer Institute), Haichuan Hu(Massachusetts General Hospital), Sana Raoof(Harvard University), Elizabeth L. Lockerman(Massachusetts General Hospital), Anuj Kalsy(Massachusetts General Hospital), Dana Lee(Massachusetts General Hospital), Celina L Keating, David A. Ruddy, Leah J. Damon(Massachusetts General Hospital), Adam Crystal(Massachusetts General Hospital), Carlotta Costa(Harvard University), Zofia Piotrowska(Harvard University), Alberto Bardelli(Candiolo Cancer Institute), A. John Iafrate(Massachusetts General Hospital), Ruslan I. Sadreyev(Massachusetts General Hospital), Frank Stegmeier, Gad Getz(Broad Institute), Lecia V. Sequist(Harvard University), Anthony C. Faber(Virginia Commonwealth University), Jeffrey A. Engelman(Harvard University)
Cited by 992Open Access
Abstract
Related Papers
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata et al.|Science Translational Medicine|2011|3.6k